Issue Special Issue 2/2002
Content (65 Articles)
The role of morphology, cytochemistry and immunohistochemistry in the diagnosis of chronic myeloproliferative diseases
Chin-Yang Li
The role of morphology, cytochemistry and immunohistochemistry in the diagnosis of lymphoproliferative disorders
Hyun-Sook Chi
Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation
Jean E. Sanders
Allogeneic hemopoietic stem cell transplantation in patients with myelodysplastic syndrome or myelofibrosis
H. Joachim Deeg, Philippe Guardiola
Targeted gene disruption of natural anticoagulant proteins in mice
Tetsuhito Kojima
Effects of hormone replacement therapy on coagulation and fibrinolysis in postmenopausal women
Kwang Kon Koh
Recent advances in the diagnosis of antiphospholipid syndrome
Hyun-Sook Chi
Monitoring the course of chronic myelogenous leukemia by fluorescencein Situ hybridization
Chu-Myong Seong
Integrating cytogenetics and gene expression profiling in the molecular analysis of Multiple Myeloma
John D. Shaughnessy, Bart Barlogie
Cytogenetic and FISH studies in myelodysplasia, acute myeloid leukemia, chronic lymphocytic leukemia and lymphoma
Gordon Dewald W.
Pediatric apheresis: Special emphasis on peripheral blood progenitor cell harvest in children
Haewon C. Kim
The eight-year experience of plasmapheresis in patients with neurological diseases
Hou-Chang Chiu, Jiann-Horng Yeh, Wei-Hung Chen
Thalassemia and abnormal hemoglobin
Suthat Fucharoen, Pranee Winichagoon
Thalassemia mutations and their clinical aspects in Japan
Yukio Hattori
β-Thalassaemia prototype of a single gene disorder with multiple phenotypes
Swee Lay Thein
Carrier screening and genetic counselling in β-thalassemia
Antonio Cao
High dose chemotherapy and autologous transplantation for non-Hodgkin’s lymphoma
Julie M. Vose
Idiopathic thrombocytopenic purpura: Pathophysiology and management
Yeon S. Ahn, Lawrence L Horstman
Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura
Han-Mou Tsai
Management of bleeding disorders by prohemostatic therapy
Marcel M. Levi, Roel Vink, Evert de Jonge
Current and emerging technology for HLA typing
Derek Middleton
HLA diversity: Detection and impact on unrelated hematopoietic stem cell · donor characterization and selection
Carolyn Katovich Hurley
Minor histocompatibility antigens-targets of graft versus leukemia responses
Stanley R. Riddell, M. Murata, S. Bryant, E. H. Warren
Views on the pathophysiology of aplastic anaemia
Edward C. Gordon-Smith, J. C. Marsh, F. M. Gibson
New advances in the treatment of acquired severe aplastic anaemia
Jill Hows
The relationship of aplastic anemia and PNH
Neal S. Young, Jaroslaw P. Maciejewski, Elaine Sloand, Guiben Chen, Weihua Zeng, Antonio Risitano, Akira Miyazato
Clinical importance of genetic findings in adult AML
Clara D. Bloomfield
Biologically risk directed therapy for improved trial development and outcomes in patients with AML
Robert J. Arceci
New advances in the treatment of acute promyelocytic leukemia
Dan Douer
Clinical and scientific advances in the philadelphia-chromosome negative chronic myeloproliferative disorders
Ruben A. Mesa
Real-time PCR for monitoring minimal residual disease and chimerism in patients after allogeneic transplantation
Ahmet H. Elmaagacli
Biology and modulation of multidrug resistance (MDR) in hematological malignancies
Masao Hirose
Important features of myelodysplastic syndrome
Wolf-K. Hofmann, H. Phillip Koeffler
The Myelodysplastic Syndromes: Morphology, risk assessment, and clinical management (2002)
John M. Bennett, Peter A. Kouides, Stephen J. Forman
Human T lymphotropic virus type-I and adult T-cell leukemia in Japan
Kazunari Yamaguchi, Toshiki Watanabe
Human herpesvirus 6 and human herpesvirus 7: Emerging pathogens in transplant patients
Duncan A. Clark
Pathogen inactivation of blood components: Current status and introduction of an approach using riboflavin as a photosensitizer
Frank Corbin
The quest for quality blood banking program in the new millennium the American way
Dae Un Kim
An approach to the diagnosis and treatment of bleeding disorders in infants
Thomas C. Abshire
Non-myeloablative hematopoietic cell transplant for treatment of nonmalignant disorders in children
Ann E. Woolfrey, Michael A. Pulsipher, Rainer Storb
Current concepts in treatment of childhood acute lymphoblastic leukemia
Ching-Hon Pui
Childhood acute lymphoblastic Leukemia: Differences in drug resistance between sub-groups of ALL
A. J. P. Veerman
Umbilical cord blood for unrelated bone marrow replacement; Asia Bank and Japan cord blood bank network update
Hideo Mugishima, Tuneo Takahashi, Tokiko Nagamura, Sigetaka Asano, Hidehiko Saito
Role of the Advanced Practice Nurse in blood and marrow transplantation
Joyce L. Neumann
Research within the field of blood and marrow transplantation nursing: How can it contribute to higher quality of care?
Monica C. Fliedner
The present state of advanced practice nursing in hematopoietic stem cell transplantation field in Korea
Jung Hee Hong
Treatment of polycythemia vera with recombinant interferon
Richard T. Silver
The therapy of myelofibrosis: Targeting pathogenesis
Ruben A. Mesa
Basic sciences of the myeloproliferative diseases: Pathogenic mechanisms of ET and PV
Rosemary E. Gale
What is the standard treatment in essential thrombocythemia
Tiziano Barbui